-+ 0.00%
-+ 0.00%
-+ 0.00%

Revolution Medicines plans USD 750 million follow-on common stock offering

PUBT·04/13/2026 20:03:11
Listen to the news
Revolution Medicines plans USD 750 million follow-on common stock offering
  • Revolution Medicines launched separate public offerings of USD 750 million common stock and USD 250 million convertible senior notes due 2033.
  • Underwriters hold 30-day options for up to USD 112.5 million additional common stock and up to USD 37.5 million additional notes for over-allotments.
  • Convertible notes will be senior unsecured, pay semiannual interest, mature May 1, 2033.
  • Issuer may redeem notes for cash on or after May 6, 2030 if stock trades above 130% of conversion price for a specified period.
  • Net proceeds targeted for general corporate purposes, including R&D and potential commercialization spending.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Revolution Medicines Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604131601PRIMZONEFULLFEED9688855) on April 13, 2026, and is solely responsible for the information contained therein.